Tuesday, June 07, 2005 7:28:10 AM
The very real prospect of all this certainly gives any rational investor in this company pause for serious concern, particularly if the investor is down more than 90% from his original investment and is hanging on only for the slim chance of minimizing losses, not because there is any great confidence in the company ever doing well going forward.
Of course, all this can be avoided by the company securing at least one significant revenue generating deal, an accomplishment that has been so far elusive and there is no indication or prospect that this will be realized because no legitimate biotech/pharma company has ever expressed an interest in buying, licensing or joint venturing what DNAP has to offer to any significant degree.
I think our only hope is for Frudakis and his cronies to make a miracle happen, and that is exactly the hope which feeds and supports the more enthusiastic longs among us in this investment. JMHO
dr f
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM